AB
HBIO icon

Amalgamated Bank’s Harvard Bioscience HBIO Stock Holding History

Amalgamated Bank’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-132
Closed -$1K – 3059
2025
Q1 		$1K Hold
132
– – ﹤0.01% 2911
2024
Q4 		$3K Hold
132
– – ﹤0.01% 2849
2024
Q3 		$4K Hold
132
– – ﹤0.01% 2816
2024
Q2 		$4K Hold
132
– – ﹤0.01% 2852
2024
Q1 		$6K Sell
132
-422
-76% -$19K ﹤0.01% 2641
2023
Q4 		$30K Sell
554
-39
-7% -$1.76K ﹤0.01% 2460
2023
Q3 		$25K Hold
593
– – ﹤0.01% 2541
2023
Q2 		$33K Buy
+593
New +$32.5K ﹤0.01% 2490
2022
Q2 		– Sell
-620
Closed -$38K – 3104
2022
Q1 		$38K Buy
+620
New +$36.7K ﹤0.01% 2592

Other funds holding HBIO

AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Amalgamated Bank's HBIO Position: Q2 2025 in Review

Amalgamated Bank sold out of Harvard Bioscience (HBIO) in Q2 2025, closing a stake of 132 shares — an estimated $1K sold.

Amalgamated Bank first reported a position in HBIO in Q1 2022 and held it in 9 quarters. The position peaked at $38K in Q1 2022. 68 funds tracked by Wall St. Rank hold HBIO as of Q2 2025.

  • Amalgamated Bank reported no remaining Harvard Bioscience position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 132 Harvard Bioscience shares in Q2 2025, an estimated $1K.
  • Amalgamated Bank first reported a position in Harvard Bioscience in Q1 2022 and held it in 9 quarters.
  • Amalgamated Bank's Harvard Bioscience position peaked at $38K in Q1 2022.
  • 68 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.